Patients
Patients who were followed up on for more than 48 hours in ICU and more
than 72 hours in medical wards due to COVID-19 between March 19 and
September 1, 2020 were included in the study. We excluded the following
patients, (1) those who have neurodegenerative diseases, (2) those who
were readmitted to the hospital due to any other conditions, (3) those
with impaired movement due to physical disabilities. Patients were
included in the study for at least 6 months, after discharge from the
hospital.
The diagnosis of COVID-19 was based on World Health Organization (WHO)
interim guidance18. Antiviral treatment against severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was given
according to Turkish Ministry of Health COVID-19
Guidance19.